Human serum albumin-induced modification of Ton-B-dependent receptor expression in cefiderocol-exposed carbapenem-resistant Acinetobacter baumannii.
作者信息
Nishimura Brent, Escalante Jenny, Mezcord Vyanka, Tuttobene Marisel R, Subils Tomás, Actis Luis A, Pasteran Fernando, Tolmasky Marcelo E, Bonomo Robert A, Ramirez María Soledad
机构信息
Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, USA.
Área Biología Molecular, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina.
出版信息
Int J Antimicrob Agents. 2023 Nov;62(5):106950. doi: 10.1016/j.ijantimicag.2023.106950. Epub 2023 Aug 18.
Abstract
摘要
相似文献
1
Human serum albumin-induced modification of Ton-B-dependent receptor expression in cefiderocol-exposed carbapenem-resistant Acinetobacter baumannii.
Int J Antimicrob Agents. 2023 Nov;62(5):106950. doi: 10.1016/j.ijantimicag.2023.106950. Epub 2023 Aug 18.
2
Role of β-lactamase inhibitors on cefiderocol activity against carbapenem-resistant Acinetobacter species.
Int J Antimicrob Agents. 2023 Jan;61(1):106700. doi: 10.1016/j.ijantimicag.2022.106700. Epub 2022 Dec 5.
3
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA.
J Antimicrob Chemother. 2024 Apr 2;79(4):928-930. doi: 10.1093/jac/dkae018.
4
Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence.
Int J Antimicrob Agents. 2023 Aug;62(2):106882. doi: 10.1016/j.ijantimicag.2023.106882. Epub 2023 Jun 8.
5
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis.
Int J Antimicrob Agents. 2024 Jun;63(6):107167. doi: 10.1016/j.ijantimicag.2024.107167. Epub 2024 Apr 4.
6
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1451-1457. doi: 10.1007/s10096-022-04503-7. Epub 2022 Oct 6.
7
Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis.
Clin Microbiol Infect. 2024 Feb;30(2):178-188. doi: 10.1016/j.cmi.2023.08.029. Epub 2023 Sep 4.
8
Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-Resistant Gram-Negative Bacilli in an Chemostat Model.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01128-20.
9
Activity of Cefiderocol Against , , and Endemic to Medical Centers in New York City.
Microb Drug Resist. 2020 Jul;26(7):722-726. doi: 10.1089/mdr.2019.0298. Epub 2020 Feb 7.
10
Clinical evidence supporting cefiderol for serious Acinetobacter baumannii infections.
Curr Opin Infect Dis. 2022 Dec 1;35(6):545-551. doi: 10.1097/QCO.0000000000000880.
引用本文的文献
1
Antimicrobial Activity of CRL 2244 Extracts Against Community- and Hospital-Acquired .
Antibiotics (Basel). 2025 Aug 8;14(8):812. doi: 10.3390/antibiotics14080812.
2
Lacticaseibacillus rhamnosus CRL 2244 secreted metabolites display killing and antibiotic synergistic activity against multi-drug resistant pathogens.
PLoS One. 2024 Jun 28;19(6):e0306273. doi: 10.1371/journal.pone.0306273. eCollection 2024.
3
Insights into the activity of cefiderocol against PER-2 producing Enterobacterales.
Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0172023. doi: 10.1128/aac.01720-23. Epub 2024 May 1.
本文引用的文献
1
The Iron Content of Human Serum Albumin Modulates the Susceptibility of to Cefiderocol.
Biomedicines. 2023 Feb 20;11(2):639. doi: 10.3390/biomedicines11020639.
2
Human Serum Proteins and Susceptibility of to Cefiderocol: Role of Iron Transport.
Biomedicines. 2022 Mar 3;10(3):600. doi: 10.3390/biomedicines10030600.
3
Interplay between Meropenem and Human Serum Albumin on Expression of Carbapenem Resistance Genes and Natural Competence in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0101921. doi: 10.1128/AAC.01019-21. Epub 2021 Jul 19.
4
Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in to Enhance Cytotoxicity and Immune Evasion.
Front Microbiol. 2019 Jul 17;10:1581. doi: 10.3389/fmicb.2019.01581. eCollection 2019.
5
AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.
mBio. 2014 May 27;5(3):e01076-14. doi: 10.1128/mBio.01076-14.
6
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.
Antimicrob Agents Chemother. 2006 Dec;50(12):4114-23. doi: 10.1128/AAC.00778-06. Epub 2006 Sep 25.
Zotero 插件